Multicentre GMK UNI Anatomical Cementless Study - FR

PROSPECTIVE, MULTICENTRE POST-MARKETING SURVEILLANCE STUDY to ASSESS PERFORMANCE of the GMK UNI ANATOMICAL CEMENTLESS IMPLANT

Unicompartmental Knee Arthroplasty (UKA) is the principal surgical alternative to Total Knee Arthroplasty (TKA) in patients with end-stage unicompartmental tibiofemoral osteoarthritis (OA) of the knee. The current post-marketing surveillance study aims to monitor GMK-UNI monocompartmental knee prosthesis performances over a 10-year time period.

Inclusion Criteria:

• Patients presenting with disease that meets the indications for use for Medacta implants included in this study (on-label use);
• Patients who are willing and able to provide written informed consent for participation in the study. Written informed consent must be obtained prior to the patient's surgery;
• Patient's age between 18 and 75 years old;
• Patients must be willing to comply with the pre and postoperative evaluation schedule.

Exclusion Criteria:

• Patients with one or more medical conditions identified as a contraindication defined by the labelling on any Medacta implants used in this study;
• Any patient who cannot or will not provide informed consent for participation in the study;
• Patients who need a revision surgery
• Patients unable to understand and take action;
• Any case not described in the inclusion criteria;
• Patients aged under 18 years;
• Patients aged over 75 years;